Skip to content

Home
About Us
- Board of Directors
- Management Team
Technology
News/Resources
Investor Centre
Contacts

ASX Announcements 2018

14 Dec 2018
Appendix 3B – New Issue Announcement
12 Dec 2018
Shareholder Update
5 Dec 2018
Exercise of Options Raises $4.7 Million
30 Nov 2018
Appendix 3B – New Issue Announcement
28 Nov 2018
Presentation of BIT225-009 HIV-1 Phase 2 Data
23 Nov 2018
Appendix 3Y – Change of Director’s Interest Notice
23 Nov 2018
Appendix 3B – New Issue Announcement
22 Nov 2018
Change of Principal Place of Business
20 Nov 2018
Results of Annual General Meeting
20 Nov 2018
Reappointment of a Director
20 Nov 2018
Presentation to Annual General Meeting
16 Nov 2018
Appendix 3B – New Issue Announcement
13 Nov 2018
Presentation of BIT225-009 HIV-1 Phase 2 Data
9 Nov 2018
Appendix 3B – New Issue Announcement
9 Nov 2018
Appendix 3Y – Change of Director’s Interest Notice
2 Nov 2018
Appendix 3Y – Change of Director’s Interest Notice
2 Nov 2018
Appendix 3B – New Issue Announcement
30 Oct 2018
Biotron Response to ASX Aware Query
29 Oct 2018
Option Expiry Notice
29 Oct 2018
Appendix 3B – New Issue Announcement
25 Oct 2018
Appendix 3Y – Change of Director’s Interest Notice
25 Oct 2018
Appendix 3B – New Issue Announcement
25 Oct 2018
Presentation to Investors
24 Oct 2018
Appendix 3B – New Issue Announcement
24 Oct 2018
Quarterly Report 30 September 2018
23 Oct 2018
Appendix 3B – New Issue Announcement
23 Oct 2018
Appointment of a Director
22 Oct 2018
Appendix 3B – New Issue Announcement
18 Oct 2018
Appendix 3B – New Issue Announcement
18 Oct 2018
Appendix 3B – New Issue Announcement
18 Oct 2018
Annual Report and Notice of AGM
17 Oct 2018
Biotron Secures $4.7 Million Underwriting Agreement
15 Oct 2018
R&D Tax Incentive
11 Oct 2018
Appendix 3B – New Issue Announcement
9 Oct 2018
Shareholder Update
28 Sep 2018
Significant Immunological Outcomes in BIT225 HIV-1 Clinical Trial
29 Aug 2018
Appendix 4G and Corporate Governance Statement 2018
29 Aug 2018
Year End Accounts and Preliminary Final Report
7 Aug 2018
Update on Progress of BIT225 Phase 2 HIV-1 Clinical Trial
11 Jul 2018
Quarterly Report 30 June 2018
14 Jun 2018
Appendix 3B – New Issue Announcement
12 Jun 2018
New Issue Oversubscribed
28 May 2018
Appendix 3B – New Issue Announcement
16 May 2018
Appendix 3B – New Issue Announcement
14 May 2018
Response to ASX Appendix 4C Query
14 May 2018
Response to ASX Price Query
11 May 2018
Letter to Eligible and Ineligible Shareholders
10 May 2018
Prospectus
10 May 2018
Letter to Option Holders
10 May 2018
Appendix 3B – New Issue Announcement
10 May 2018
Renounceable Rights Issue
9 May 2018
Request for Trading Halt
26 Apr 2018
Quarterly Report 31 March 2018
6 Apr 2018
Update on Progress of BIT225 Phase 2 HIV-1 Clinical Trial
20 Feb 2018
Half-year Report 31 December 2017
16 Jan 2018
Quarterly Report 31 December 2017
10 Jan 2018
Biotech Showcase 2018 Presentation
10 Jan 2018
Biotron Limited Presents at Biotech Showcase 2018

<<
2024

2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
>>

Investor Centre

Investor Centre

© Biotron Limited 2016 ABN 60 086 399 144 Site updated 25 September 2024 Legal Notices and Privacy